Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Gascon P, Krendyukov A, Höbel N, Aapro M. Treatment patterns and outcomes in the DLBCL cohort of a study (MONITOR-GCSF) assessing biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_102] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]

For:	Gascon P, Krendyukov A, Höbel N, Aapro M. Treatment patterns and outcomes in the DLBCL cohort of a study (MONITOR-GCSF) assessing biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_102] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]

Number

Cited by Other Article(s)

Schiestl M, Krendyukov A. The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information. ESMO Open 2017;2:e000245. [PMID: 29071126 PMCID: PMC5640113 DOI: 10.1136/esmoopen-2017-000245] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2017] [Accepted: 07/11/2017] [Indexed: 11/24/2022] Open